MARPE Effect With/Without MOP in Non-growing Patients
- Conditions
- Maxillary Transverse Deficiency
- Interventions
- Procedure: MARPE without MOPProcedure: MARPE with MOP
- Registration Number
- NCT06502041
- Lead Sponsor
- Mansoura University
- Brief Summary
This study compares the effect of MARPE (mini-implant assisted rapid palatal expansion) versus MARPE+ MOP (Micro-osteo-perforation) on nasal airway and maxillary transverse deficiency in non-growing patients.
- Detailed Description
All participants with skeletal transverse deficiency with unilateral or bilateral cross-bite aging 20-25 years were treated by expansion of maxillary arch as a first phase of treatment with one expander screw which was anchored to mini-implants placed in the palatal region (Mini-implant assissted rapid palatal expansion; MARPE). The patient's bone support in the anterior area of the palate was examined on CBCT. Micro-osteoperforation (MOP) was done along of medial palatine raphe in the intervention group. Control-group is the same of the intervention group but without micro-osteo-perforations.
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 24
- The age ranges from 20-25 years.
- Post pubertal adolescent
- Skeletal transverse deficiency with unilateral or bilateral cross-bite
- Extraction is not indicated in the lower arch.
- Upper permanent dentition is erupted up to the second molars.
- Average facial vertical growth pattern.
- Space deficiency in the upper arch is less than 8 mm
-
Diseases and medications those are likely to affect bone biology.
-
Evidence of root resorption.
-
Poor oral hygiene.
-
Previous orthodontic treatment.
-
Evidence of bone loss.
-
Active periodontal disease.
-
Craniofacial congenital anomalies, such as cleft lip and palate.
-
Pregnant females. 8. Presence of oral habits.
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- PARALLEL
- Arm && Interventions
Group Intervention Description MARPE without MOP MARPE without MOP - MARPE with MOP MARPE with MOP -
- Primary Outcome Measures
Name Time Method Stability of correction of transverse deficiency about 6 months by measuring the same CBCT transverse reading and by superimposition of the scaneed models at the end of the research
Pain experience during activation of expander by visual analogue scale ( VAS) about 1 months VAS: 0 ( no pain), 10 (unbearable pain)
Number of days till diastema appearance about 1 month (days)
Amount of skeletal expansion about 1 month (mm)
Skeletal, Dental & Nasal readings measured before treatment and after 6 month of treatment from CBCT and scanned models measured in degrees \& mm
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Mansoura University
🇪🇬Mansoura, Adakhlia, Egypt